文献速递糖尿病肥胖与代谢综合征

新诊断2型糖尿病合并脂肪性肝病者早期餐后胰高血糖素升高

Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.
PubMed 文献 · Diabetes Care · 2026-01-01

研究纳入50例新诊断T2D和50例年龄、性别、BMI匹配的NGT个体,行混合餐耐量试验、高胰岛素正葡萄糖钳夹及磁共振波谱检查。T2D者肝脂含量高约65%,空腹和餐后胰高血糖素分别高约30%和约75%;MASLD而非T2D与空腹胰高血糖素升高相关,餐后胰高血糖素仅与T2D者的肝脂含量相关。

要点

  • 新诊断T2D者空腹及餐后胰高血糖素均升高,肝脂含量亦升高。
  • MASLD与空腹胰高血糖素升高相关,餐后胰高血糖素与肝脂关联仅见于T2D。
  • 该关联独立于胰岛素敏感性和内脏脂肪,提示肝脏胰高血糖素抵抗。

核心结论

  • 早期T2D伴肝脂增高时的高胰高血糖素血症并非由胰岛素敏感性差异或胰高血糖素促分泌代谢物介导,可能提示肝脏胰高血糖素抵抗。

研究设计与样本

  • 研究纳入50例新诊断T2D和50例年龄、性别、BMI匹配的NGT个体。
  • 受试者接受液体混合餐耐量试验、高胰岛素正葡萄糖钳夹联合稳定同位素稀释、间接测热法,以及1H/31P磁共振波谱和MRI。

主要发现

  • T2D个体肝脂含量较NGT高约65%,空腹和餐后胰高血糖素分别高约30%和约75%。
  • 多变量线性回归显示MASLD而非T2D与空腹胰高血糖素升高相关。
  • 餐后胰高血糖素仅与T2D者的肝脂含量相关,合并MASLD和T2D者早期餐后胰高血糖素高约47%。
  • 上述差异关联独立于胰岛素敏感性或内脏脂肪体积,且不由氨基酸或非酯化脂肪酸介导。

临床怎么用

  • 对新诊断T2D合并MASLD者,应关注早期餐后胰高血糖素升高及潜在肝脏胰高血糖素抵抗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Glucagon-based polyagonists improve metabolic dysfunction-associated steatotic liver disease (MASLD), which could result from glucagon-stimulated hepatic lipid oxidation. Nevertheless, people with long-standing type 2 diabetes (T2D) exhibit a paradoxical rise in both hepatic lipid content (HLC) and glucagon levels, which has been related to disturbed hepatic metabolism generating glucagonotropic metabolites such as amino acids and nonesterified fatty acids (NEFAs). We examined these relationships in individuals with normal glucose tolerance (NGT) and newly diagnosed T2D. RESEARCH DESIGN AND METHODS: Fifty individuals with newly diagnosed T2D and 50 age-, sex-, and BMI-matched individuals with NGT underwent liquid mixed-meal tolerance tests to measure glucagon and metabolites, hyperinsulinemic-euglycemic clamps with stable isotope dilution, indirect calorimetry to assess insulin sensitivity and lipid oxidation, and 1H/31P magnetic resonance spectroscopy and MRI to quantify HLC, ATP, and visceral adipose tissue (VAT) volume. RESULTS: Individuals with T2D had an ∼65% higher HLC as well as higher fasting and postprandial glucagonemia (∼30% and ∼75%) than those with NGT. Multivariable linear regression analyses revealed that the presence of MASLD, but not T2D, was associated with higher fasting glucagonemia. Interestingly, postprandial glucagon was related to HLC only in T2D, leading to ∼47% higher early postprandial glucagonemia in individuals with combined MASLD and T2D. These differential associations were independent of insulin sensitivity or VAT volume, and neither were mediated by amino acids or NEFAs. CONCLUSIONS: Hyperglucagonemia in the face of higher HLC in early T2D is not due to differences in insulin sensitivity or glucagonotropic metabolites but could suggest hepatic glucagon resistance.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Huttasch M, Kahl S, Mori T, et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease. Diabetes Care. 2026. PMID: 41931030. doi:10.2337/dc25-3077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。